Guangdong Provincial Key Laboratory of Digital Biology and Drug Development is focused on transforming drug development through digital biotechnology, integrating AI, machine learning, big data analytics, and bioinformatics to enhance the efficiency and success rate of drug discovery. These technologies enable faster screening of drug candidates, precise drug-target interaction predictions, and improved personalized treatment, reducing both costs and development time. Aiming to foster interdisciplinary collaboration, the lab brings together expertise from biology, chemistry, medicine, computer science, and data science. Its hybrid research model combines in silico simulations with in vitro/in vivo experiments, utilizing a high-performance computing platform and advanced lab equipment. This approach accelerates drug development and facilitates the transition from discovery to clinical trials.

Spanning 2,600 square meters and equipped with 364 high-value instruments, the lab hosts a team of renowned scholars and international talents. It focuses on areas such as molecular simulations, drug target discovery, bioinformatics, and AI-driven drug development, fostering strong collaborations with industry and academia. The lab also emphasizes talent development, aiming to train interdisciplinary experts in digital biotechnology and pharmaceutical sciences. By promoting international collaborations, high-level academic events, and expanding its global influence, the lab aspires to become a leader in bioinformatics and drive technological advancements in the biopharmaceutical industry.